SCHEMBL4635526

SCHEMBL4635526

O=c1cnc2c(cn1)CNN2

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ MB P02144 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1343779 0.54 — —
SCHEMBL2916684 0.51 — —
SCHEMBL17104907 0.51 — —
SCHEMBL3154784 0.50 — —
SCHEMBL3504168 0.48 — —
SCHEMBL10597749 0.47 — —
SCHEMBL261513 0.47 — —
SCHEMBL17728312 0.44 — —
SCHEMBL5054063 0.44 — —
SCHEMBL30920011 0.44 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1931672-A1 NOVEL 5,6-DIHYDROPYRAZOLO[3,4-E] [L,4]DIAZEPIN-4 (IH) -ONE DERIVATIVES FOR THE TREATMENT OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE. AstraZeneca AB (SE) 2008-06-18 — — EP disclosed
WO-2007040435-A1 NOVEL 5,6-DIHYDROPYRAZOLO[3,4-E] [L,4]DIAZEPIN-4 (IH) -ONE DERIVATIVES FOR THE TREATMENT OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE. ASTRAZENECA AB (SE) 2007-04-12 — — WO disclosed
Send feedback